Cantor Fitzgerald downgrades Rosetta Genomics Ltd. (Nasdaq: ROSG) from Buy to Hold. Price target slashes from $11 to $3.

Cantor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE